In 2021, the 44-year UK Prospective Diabetes Study (UKPDS) follow-up results were presented at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD).1 In one of the longest ever studies of diabetes, it showed that the benefits of early blood glucose control in type 2 diabetes mellitus (T2DM) persist for decades.1
Starting in 1977, the UKPDS randomly allocated newly diagnosed patients to an intensive blood glucose control strategy with sulfonylurea/insulin, or if overweight,...
